文献速递肾移植

肾移植中Eplet错配作为移植失败决定因素的层级研究

On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss.
PubMed 文献 · Kidney Int Rep · 2021-03-30

本研究基于118,313例0% PRA首次肾移植受者,将供受者HLA等位基因转换为Eplet错配(EMM)集,分析其与死亡删失的移植失败(DCGF)的关联。

要点

  • 特定EMM与肾移植DCGF风险增加相关,支持其作为免疫优势EMM。
  • 网络分析揭示EMM共存模式,有助于区分独立与协同效应。
  • 筛选出的EMM子集可能优化器官分配方案。

核心结论

  • 分析区分出越来越小的EMM子集与DCGF风险增加相关。
  • 验证这些EMM作为移植结果重要预测因子将支持其作为免疫优势EMM用于器官分配。

研究设计与样本

  • 研究队列为118,313例美国0% PRA首次肾移植受者(2000-2015),来自SRTR。
  • 将推算的供受者HLA-A、-B、-C、-DRB1、-DQB1等位基因型转换为EMM集。
  • 对每个EMM拟合生存模型,采用FDR校正显著性阈值,并在独立PRA>0%队列中验证。
  • 进行基于网络的分析建模EMM间关系,并开发模型选择最能预测DCGF的EMM子集。

主要发现

  • 观察到的412个EMM中,119个I类和118个II类EMM与DCGF相关。
  • 网络分析显示210个Eplet形成2至12个同时发生的EMM谱,202个为孤立EMM不参与任何谱。
  • 变量选择在70%数据集中识别出55个单一HLA I类和II类EMM。
  • 其中15个EMM(9个孤立和6个参与谱)在剩余数据集中预测DCGF。

临床怎么用

  • EMM可作为肾移植风险分层工具,指导免疫抑制策略。
  • 验证后的免疫优势EMM可考虑纳入器官分配方案。

局限性

  • 研究基于推算的等位基因型,需在实测等位基因型数据集中验证。
  • 结论主要适用于0% PRA首次肾移植受者,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: To mitigate risks related to human leukocyte antigen (HLA) incompatibility, we assessed whether certain structurally defined HLA targets present in donors but absent from recipients, known as eplet mismatches (EMM), are associated with death-censored graft failure (DCGF). METHODS: We studied a cohort of 118,313 American 0% panel reactive antibodies (PRA) first kidney transplant recipients (2000 to 2015) from the Scientific Registry of Transplant Recipients. Imputed allele-level donor and recipient HLA-A, -B, -C, -DRB1, and -DQB1 genotypes were converted to the repertoire of EMM. We fit survival models for each EMM with significance thresholds corrected for false discovery rate and validated those in an independent PRA > 0% cohort. We conducted network-based analyses to model relationships among EMM and developed models to select the subset of EMM most predictive of DCGF. RESULTS: Of 412 EMM observed, 119 class I and 118 class II EMM were associated with DCGF. Network analysis showed that although 210 eplets formed profiles of 2 to 12 simultaneously occurring EMMs, 202 were singleton EMMs that were not involved in any profile. A variable selection procedure identified 55 single HLA class I and II EMMs in 70% of the dataset; of those, 15 EMMs (9 singleton and 6 involved in profiles) were predictive of DCGF in the remaining dataset. CONCLUSION: Our analysis distinguished increasingly smaller subsets of EMMs associated with increased risk of DCGF. Validation of these EMMs as important predictors of transplant outcomes (in contrast to acceptable EMMs) in datasets with measured allele-level genotypes will support their role as immunodominant EMMs worthy of consideration in organ allocation schemes.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Mohammadhassanzadeh H, Oualkacha K, Zhang W, et al. On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss. Kidney Int Rep. 2021. PMID: 34169197. doi:10.1016/j.ekir.2021.03.877

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。